Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 46 | 2023 | 2360 | 4.730 |
Why?
|
Proto-Oncogene Proteins B-raf | 26 | 2023 | 2059 | 3.650 |
Why?
|
Thyroidectomy | 23 | 2023 | 913 | 2.340 |
Why?
|
Indoles | 11 | 2018 | 1836 | 2.060 |
Why?
|
Sulfonamides | 11 | 2018 | 1982 | 2.050 |
Why?
|
Thyroid Nodule | 12 | 2021 | 767 | 1.830 |
Why?
|
Thrombospondin 1 | 7 | 2013 | 257 | 1.400 |
Why?
|
Thyroid Gland | 12 | 2023 | 1171 | 1.290 |
Why?
|
Carcinoma, Papillary | 11 | 2017 | 793 | 1.140 |
Why?
|
Physicians, Women | 5 | 2020 | 517 | 1.020 |
Why?
|
Thyroid Diseases | 6 | 2019 | 385 | 1.020 |
Why?
|
MAP Kinase Signaling System | 6 | 2021 | 1495 | 0.960 |
Why?
|
Endocrinology | 3 | 2023 | 443 | 0.800 |
Why?
|
Hyperparathyroidism | 3 | 2021 | 339 | 0.740 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2015 | 326 | 0.700 |
Why?
|
Sexual Harassment | 1 | 2020 | 82 | 0.650 |
Why?
|
Body Image | 1 | 2023 | 646 | 0.620 |
Why?
|
Carcinoma | 5 | 2015 | 2332 | 0.600 |
Why?
|
Apoptosis | 10 | 2017 | 9527 | 0.600 |
Why?
|
Biopsy, Fine-Needle | 14 | 2021 | 1132 | 0.600 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17142 | 0.570 |
Why?
|
Leadership | 4 | 2019 | 1397 | 0.570 |
Why?
|
Phenylurea Compounds | 2 | 2019 | 531 | 0.560 |
Why?
|
Parathyroid Neoplasms | 5 | 2016 | 244 | 0.550 |
Why?
|
Angiogenesis Inhibitors | 5 | 2007 | 2057 | 0.540 |
Why?
|
Oxyphil Cells | 2 | 2023 | 56 | 0.540 |
Why?
|
Nitrophenols | 1 | 2017 | 169 | 0.540 |
Why?
|
Parathyroid Diseases | 2 | 2019 | 46 | 0.530 |
Why?
|
Mice, SCID | 12 | 2016 | 2627 | 0.530 |
Why?
|
Mutation | 15 | 2024 | 30237 | 0.520 |
Why?
|
Antigens, Neoplasm | 2 | 2014 | 1996 | 0.510 |
Why?
|
Vocal Cord Paralysis | 2 | 2017 | 275 | 0.510 |
Why?
|
Endostatins | 2 | 2007 | 167 | 0.510 |
Why?
|
Graves Disease | 2 | 2015 | 239 | 0.490 |
Why?
|
Azacitidine | 2 | 2014 | 336 | 0.490 |
Why?
|
Neovascularization, Pathologic | 13 | 2010 | 2631 | 0.490 |
Why?
|
Societies, Medical | 6 | 2020 | 3968 | 0.450 |
Why?
|
Parathyroidectomy | 5 | 2021 | 244 | 0.450 |
Why?
|
General Surgery | 4 | 2019 | 1720 | 0.450 |
Why?
|
Adrenalectomy | 5 | 2022 | 348 | 0.440 |
Why?
|
Quinolines | 1 | 2019 | 772 | 0.430 |
Why?
|
Awards and Prizes | 1 | 2017 | 365 | 0.410 |
Why?
|
Ultrasonography | 12 | 2021 | 6004 | 0.390 |
Why?
|
Cholecystitis | 3 | 2006 | 181 | 0.390 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2015 | 342 | 0.390 |
Why?
|
Mice | 37 | 2024 | 82049 | 0.390 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3948 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 1406 | 0.380 |
Why?
|
Biphenyl Compounds | 1 | 2017 | 1026 | 0.380 |
Why?
|
src-Family Kinases | 1 | 2014 | 539 | 0.380 |
Why?
|
Vocal Cords | 1 | 2015 | 520 | 0.370 |
Why?
|
Larynx | 1 | 2015 | 492 | 0.360 |
Why?
|
Physicians' Offices | 1 | 2011 | 60 | 0.360 |
Why?
|
Endocrine Glands | 1 | 2010 | 101 | 0.360 |
Why?
|
Protein Kinase Inhibitors | 6 | 2019 | 5704 | 0.350 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2017 | 5341 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2015 | 8648 | 0.340 |
Why?
|
Laryngoscopy | 1 | 2015 | 714 | 0.340 |
Why?
|
Humans | 118 | 2024 | 768171 | 0.330 |
Why?
|
Incidental Findings | 4 | 2013 | 698 | 0.330 |
Why?
|
Antineoplastic Agents | 8 | 2024 | 13677 | 0.330 |
Why?
|
Hyperparathyroidism, Primary | 3 | 2021 | 164 | 0.330 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2018 | 3612 | 0.320 |
Why?
|
Internship and Residency | 4 | 2022 | 5953 | 0.320 |
Why?
|
Animals | 46 | 2024 | 169285 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2459 | 0.300 |
Why?
|
DNA, Mitochondrial | 3 | 2024 | 872 | 0.300 |
Why?
|
Immunotherapy | 2 | 2014 | 4754 | 0.300 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2012 | 594 | 0.290 |
Why?
|
Fellowships and Scholarships | 2 | 2021 | 1135 | 0.290 |
Why?
|
Parathyroid Glands | 4 | 2024 | 522 | 0.280 |
Why?
|
Iodine Radioisotopes | 4 | 2016 | 1034 | 0.280 |
Why?
|
Antibodies, Monoclonal | 4 | 2018 | 9262 | 0.270 |
Why?
|
Pancreatic Neoplasms | 6 | 2007 | 5442 | 0.270 |
Why?
|
Female | 67 | 2024 | 397187 | 0.270 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2022 | 735 | 0.260 |
Why?
|
Immunocompetence | 2 | 2018 | 138 | 0.260 |
Why?
|
Jejunal Diseases | 1 | 2006 | 45 | 0.260 |
Why?
|
Four-Dimensional Computed Tomography | 2 | 2021 | 142 | 0.260 |
Why?
|
Intestinal Obstruction | 2 | 2007 | 433 | 0.250 |
Why?
|
Mutation, Missense | 2 | 2014 | 2592 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11878 | 0.240 |
Why?
|
Specialties, Surgical | 2 | 2021 | 391 | 0.240 |
Why?
|
Cell Division | 5 | 2024 | 4477 | 0.240 |
Why?
|
Cholelithiasis | 1 | 2006 | 408 | 0.240 |
Why?
|
Carcinoid Tumor | 1 | 2006 | 225 | 0.230 |
Why?
|
Technetium Tc 99m Sestamibi | 6 | 2021 | 184 | 0.230 |
Why?
|
Postoperative Complications | 7 | 2019 | 15833 | 0.230 |
Why?
|
Para-Aortic Bodies | 1 | 2003 | 3 | 0.230 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 2003 | 20 | 0.220 |
Why?
|
Burnout, Professional | 2 | 2023 | 711 | 0.220 |
Why?
|
Disease Models, Animal | 9 | 2020 | 18349 | 0.220 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2003 | 47 | 0.220 |
Why?
|
Parathyroid Hormone | 6 | 2024 | 1804 | 0.220 |
Why?
|
Neurofibromatosis 1 | 1 | 2008 | 561 | 0.220 |
Why?
|
Nanoparticles | 4 | 2024 | 1986 | 0.210 |
Why?
|
Genetic Fitness | 1 | 2024 | 120 | 0.210 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.210 |
Why?
|
Cell Proliferation | 7 | 2019 | 10478 | 0.210 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3604 | 0.200 |
Why?
|
Albumins | 2 | 2022 | 577 | 0.200 |
Why?
|
Neoplasm Transplantation | 4 | 2014 | 2014 | 0.200 |
Why?
|
Abscess | 1 | 2006 | 606 | 0.200 |
Why?
|
Dependovirus | 1 | 2007 | 720 | 0.200 |
Why?
|
Endothelium, Vascular | 3 | 2009 | 4428 | 0.190 |
Why?
|
Quality Indicators, Health Care | 1 | 2011 | 1805 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2846 | 0.180 |
Why?
|
In Situ Nick-End Labeling | 3 | 2008 | 611 | 0.180 |
Why?
|
Hospitals, Community | 1 | 2023 | 365 | 0.180 |
Why?
|
Deoxycytidine | 1 | 2005 | 887 | 0.180 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1230 | 0.170 |
Why?
|
Adenoma | 4 | 2016 | 2159 | 0.170 |
Why?
|
Transfection | 4 | 2014 | 5756 | 0.170 |
Why?
|
Women, Working | 1 | 2020 | 86 | 0.170 |
Why?
|
Biopsy, Needle | 3 | 2012 | 1623 | 0.170 |
Why?
|
Male | 49 | 2021 | 364731 | 0.170 |
Why?
|
Medicine | 2 | 2019 | 945 | 0.170 |
Why?
|
MicroRNAs | 1 | 2015 | 3803 | 0.160 |
Why?
|
Genes, p53 | 2 | 2014 | 714 | 0.160 |
Why?
|
Selection, Genetic | 1 | 2024 | 877 | 0.160 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2018 | 56 | 0.160 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2019 | 124 | 0.160 |
Why?
|
Nucleic Acid Denaturation | 1 | 2018 | 111 | 0.150 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2420 | 0.150 |
Why?
|
Genetic Markers | 3 | 2014 | 2603 | 0.150 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 1205 | 0.150 |
Why?
|
Middle Aged | 34 | 2022 | 223487 | 0.150 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1743 | 0.150 |
Why?
|
Retrospective Studies | 22 | 2022 | 81760 | 0.150 |
Why?
|
Gastrinoma | 1 | 2017 | 21 | 0.150 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2004 | 681 | 0.140 |
Why?
|
Methimazole | 2 | 2015 | 41 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2014 | 7876 | 0.140 |
Why?
|
Diphenylamine | 1 | 2017 | 49 | 0.140 |
Why?
|
Laryngoplasty | 1 | 2017 | 53 | 0.140 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.140 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6082 | 0.140 |
Why?
|
Antithyroid Agents | 2 | 2015 | 72 | 0.140 |
Why?
|
Calcium | 5 | 2024 | 5792 | 0.140 |
Why?
|
Aged | 26 | 2019 | 171502 | 0.140 |
Why?
|
Women's Rights | 1 | 2017 | 66 | 0.140 |
Why?
|
Diagnosis, Differential | 8 | 2015 | 13013 | 0.140 |
Why?
|
Adult | 28 | 2021 | 223646 | 0.130 |
Why?
|
Personnel Selection | 1 | 2018 | 201 | 0.130 |
Why?
|
Adenoma, Islet Cell | 1 | 1996 | 72 | 0.130 |
Why?
|
Disease Progression | 2 | 2011 | 13668 | 0.130 |
Why?
|
Carcinoma, Islet Cell | 1 | 1995 | 21 | 0.130 |
Why?
|
Paclitaxel | 2 | 2021 | 1733 | 0.130 |
Why?
|
Drainage | 2 | 2013 | 1183 | 0.130 |
Why?
|
Aneurysm | 2 | 2007 | 343 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 812 | 0.120 |
Why?
|
bcl-X Protein | 1 | 2017 | 412 | 0.120 |
Why?
|
Sesquiterpenes | 1 | 1996 | 176 | 0.120 |
Why?
|
Flow Cytometry | 3 | 2018 | 5902 | 0.120 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2019 | 3115 | 0.120 |
Why?
|
Minocycline | 1 | 1996 | 170 | 0.120 |
Why?
|
Career Choice | 1 | 2021 | 769 | 0.120 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 263 | 0.120 |
Why?
|
Malpractice | 1 | 2019 | 561 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 354 | 0.120 |
Why?
|
Cultural Diversity | 1 | 2018 | 373 | 0.120 |
Why?
|
Schools, Medical | 1 | 2021 | 883 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2022 | 975 | 0.120 |
Why?
|
Adrenal Gland Diseases | 1 | 2015 | 141 | 0.120 |
Why?
|
Tumor Burden | 3 | 2018 | 1906 | 0.110 |
Why?
|
Chromones | 1 | 2014 | 148 | 0.110 |
Why?
|
Consensus | 2 | 2021 | 3211 | 0.110 |
Why?
|
Propylthiouracil | 1 | 2013 | 68 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 565 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 757 | 0.110 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 152 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2021 | 1226 | 0.110 |
Why?
|
RNA Interference | 2 | 2014 | 2832 | 0.110 |
Why?
|
Gallbladder | 2 | 2006 | 308 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2014 | 126 | 0.110 |
Why?
|
Preoperative Care | 2 | 2013 | 2258 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1767 | 0.110 |
Why?
|
Recombinant Proteins | 4 | 2009 | 6512 | 0.110 |
Why?
|
Hypocalcemia | 1 | 2014 | 205 | 0.110 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9540 | 0.100 |
Why?
|
Aged, 80 and over | 12 | 2018 | 59626 | 0.100 |
Why?
|
Lung Neoplasms | 5 | 2022 | 13586 | 0.100 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2013 | 66 | 0.100 |
Why?
|
Pregnancy Complications | 1 | 2007 | 2973 | 0.100 |
Why?
|
United States | 11 | 2021 | 73039 | 0.100 |
Why?
|
Granzymes | 1 | 2014 | 277 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2021 | 1791 | 0.100 |
Why?
|
Neurology | 1 | 2020 | 786 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2540 | 0.100 |
Why?
|
Neoplasm Staging | 4 | 2016 | 11244 | 0.100 |
Why?
|
Otolaryngology | 1 | 2019 | 699 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
Signal Transduction | 4 | 2014 | 23648 | 0.100 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11095 | 0.100 |
Why?
|
Interferon Type I | 1 | 1996 | 569 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1778 | 0.100 |
Why?
|
Thyrotropin | 2 | 2012 | 834 | 0.100 |
Why?
|
Neck Dissection | 2 | 2010 | 201 | 0.100 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2012 | 59 | 0.100 |
Why?
|
Phosphorylation | 2 | 2014 | 8316 | 0.090 |
Why?
|
Methylation | 1 | 2014 | 1078 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1801 | 0.090 |
Why?
|
Radiopharmaceuticals | 5 | 2021 | 2735 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 8 | 2010 | 20762 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 1 | 1995 | 1062 | 0.090 |
Why?
|
Survival Rate | 3 | 2022 | 12840 | 0.090 |
Why?
|
Benzamides | 1 | 2017 | 1379 | 0.090 |
Why?
|
Needs Assessment | 1 | 2017 | 1141 | 0.090 |
Why?
|
Histamine | 1 | 2013 | 496 | 0.090 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4363 | 0.090 |
Why?
|
Time Factors | 6 | 2014 | 40220 | 0.090 |
Why?
|
Polyarteritis Nodosa | 1 | 1991 | 70 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2023 | 2885 | 0.090 |
Why?
|
Morpholines | 1 | 2014 | 584 | 0.090 |
Why?
|
Time and Motion Studies | 1 | 2011 | 143 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2334 | 0.090 |
Why?
|
Goiter | 1 | 2010 | 86 | 0.090 |
Why?
|
Ablation Techniques | 1 | 2013 | 255 | 0.090 |
Why?
|
Calcitonin | 1 | 2011 | 329 | 0.090 |
Why?
|
Coculture Techniques | 1 | 2014 | 1344 | 0.090 |
Why?
|
Cell Growth Processes | 1 | 2011 | 381 | 0.090 |
Why?
|
Current Procedural Terminology | 1 | 2011 | 101 | 0.090 |
Why?
|
Hepatic Artery | 1 | 1991 | 232 | 0.090 |
Why?
|
Lymphocytes | 2 | 2015 | 2614 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2011 | 3620 | 0.080 |
Why?
|
Academies and Institutes | 2 | 2020 | 326 | 0.080 |
Why?
|
Forecasting | 1 | 2019 | 2945 | 0.080 |
Why?
|
Cytoplasm | 1 | 2014 | 1505 | 0.080 |
Why?
|
Endothelial Cells | 3 | 2009 | 3589 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 474 | 0.080 |
Why?
|
Microscopy, Fluorescence | 2 | 2008 | 2634 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 478 | 0.080 |
Why?
|
Lymphatic Metastasis | 3 | 2012 | 2914 | 0.080 |
Why?
|
Receptors, Complement 3b | 1 | 2009 | 136 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2014 | 620 | 0.080 |
Why?
|
Valine | 1 | 2010 | 410 | 0.080 |
Why?
|
CpG Islands | 1 | 2013 | 1208 | 0.080 |
Why?
|
Lymph Nodes | 2 | 2017 | 3474 | 0.080 |
Why?
|
Economic Competition | 1 | 2011 | 223 | 0.080 |
Why?
|
Hyperthyroidism | 1 | 2010 | 292 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1151 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9419 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2010 | 8542 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2012 | 492 | 0.080 |
Why?
|
Benzenesulfonates | 1 | 2009 | 170 | 0.080 |
Why?
|
Lymphoma | 1 | 2017 | 1898 | 0.070 |
Why?
|
Serotonin | 1 | 2013 | 1043 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1120 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2785 | 0.070 |
Why?
|
Students, Medical | 1 | 2021 | 1964 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4913 | 0.070 |
Why?
|
Tumor Cells, Cultured | 5 | 2017 | 6124 | 0.070 |
Why?
|
Certification | 1 | 2011 | 420 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2021 | 21207 | 0.070 |
Why?
|
Hemorrhoids | 1 | 2007 | 19 | 0.070 |
Why?
|
Isoquinolines | 1 | 2009 | 354 | 0.070 |
Why?
|
Random Allocation | 1 | 2011 | 2395 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 22371 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3428 | 0.070 |
Why?
|
Caspase 3 | 2 | 2009 | 730 | 0.070 |
Why?
|
Sex Factors | 3 | 2021 | 10632 | 0.070 |
Why?
|
Appointments and Schedules | 1 | 2011 | 443 | 0.070 |
Why?
|
Splenic Artery | 1 | 2007 | 58 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5505 | 0.070 |
Why?
|
Niacinamide | 1 | 2009 | 418 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 548 | 0.070 |
Why?
|
Radiology Information Systems | 1 | 2011 | 533 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2554 | 0.070 |
Why?
|
Disease-Free Survival | 4 | 2022 | 6847 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3436 | 0.070 |
Why?
|
Biliary Tract Diseases | 1 | 2007 | 159 | 0.060 |
Why?
|
Calpain | 1 | 2006 | 146 | 0.060 |
Why?
|
Morbidity | 1 | 2011 | 1755 | 0.060 |
Why?
|
Laryngeal Nerves | 1 | 2006 | 57 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2014 | 3161 | 0.060 |
Why?
|
Ultrasonography, Doppler | 2 | 2005 | 463 | 0.060 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2006 | 174 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1370 | 0.060 |
Why?
|
Massachusetts | 2 | 2021 | 8890 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2011 | 829 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3556 | 0.060 |
Why?
|
Neck Muscles | 1 | 2006 | 100 | 0.060 |
Why?
|
Radiotherapy | 1 | 2012 | 1502 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2014 | 2568 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2018 | 6395 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 937 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4648 | 0.060 |
Why?
|
Glutamic Acid | 1 | 2010 | 1191 | 0.060 |
Why?
|
Oncogenes | 2 | 2023 | 1234 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1196 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 527 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4262 | 0.060 |
Why?
|
Cell Line | 2 | 2024 | 15602 | 0.060 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2006 | 145 | 0.060 |
Why?
|
Documentation | 1 | 2011 | 917 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2014 | 12801 | 0.060 |
Why?
|
Age Factors | 2 | 2012 | 18415 | 0.060 |
Why?
|
Dissection | 1 | 2006 | 299 | 0.060 |
Why?
|
Mice, Nude | 4 | 2016 | 3623 | 0.060 |
Why?
|
Lipid Peroxides | 1 | 2023 | 74 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1514 | 0.050 |
Why?
|
Abdominal Injuries | 1 | 2007 | 362 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2202 | 0.050 |
Why?
|
Cholecystitis, Acute | 1 | 2004 | 81 | 0.050 |
Why?
|
Down-Regulation | 1 | 2011 | 2939 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4091 | 0.050 |
Why?
|
Radionuclide Imaging | 4 | 2015 | 2000 | 0.050 |
Why?
|
Cell Cycle | 1 | 2011 | 2934 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2008 | 1080 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41753 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14729 | 0.050 |
Why?
|
Fermentation | 1 | 2023 | 143 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5432 | 0.050 |
Why?
|
Gene Expression | 2 | 2013 | 7601 | 0.050 |
Why?
|
Equipment Design | 1 | 2011 | 3522 | 0.050 |
Why?
|
Endothelial Growth Factors | 2 | 2003 | 672 | 0.050 |
Why?
|
Gallbladder Neoplasms | 1 | 2004 | 190 | 0.050 |
Why?
|
Adolescent | 10 | 2018 | 89169 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2011 | 1524 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2830 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5797 | 0.050 |
Why?
|
Decision Trees | 1 | 2004 | 508 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3806 | 0.050 |
Why?
|
Length of Stay | 2 | 2013 | 6498 | 0.050 |
Why?
|
Lymphokines | 2 | 2003 | 925 | 0.050 |
Why?
|
Caspases | 1 | 2005 | 882 | 0.050 |
Why?
|
Intraoperative Period | 2 | 2016 | 513 | 0.050 |
Why?
|
Osteitis Fibrosa Cystica | 1 | 2001 | 11 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10763 | 0.050 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4120 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2065 | 0.050 |
Why?
|
Granuloma, Giant Cell | 1 | 2001 | 32 | 0.050 |
Why?
|
Muscles | 1 | 2006 | 1582 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2009 | 3517 | 0.050 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2005 | 646 | 0.050 |
Why?
|
Military Medicine | 1 | 2003 | 185 | 0.050 |
Why?
|
Magnesium | 1 | 2005 | 816 | 0.050 |
Why?
|
Pinocytosis | 1 | 2021 | 63 | 0.050 |
Why?
|
Thyroglobulin | 2 | 2012 | 111 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 630 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2021 | 9561 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2006 | 1165 | 0.050 |
Why?
|
Necrosis | 1 | 2005 | 1616 | 0.050 |
Why?
|
Mastectomy, Segmental | 1 | 2006 | 974 | 0.050 |
Why?
|
Physicians | 1 | 2019 | 4598 | 0.050 |
Why?
|
Cost of Illness | 1 | 2010 | 1951 | 0.040 |
Why?
|
Hematoma | 2 | 2019 | 766 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2003 | 384 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2005 | 3533 | 0.040 |
Why?
|
Microcirculation | 1 | 2005 | 1281 | 0.040 |
Why?
|
Serum Albumin | 1 | 2023 | 677 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 969 | 0.040 |
Why?
|
Weight Loss | 1 | 2011 | 2721 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10266 | 0.040 |
Why?
|
Appendicitis | 1 | 2007 | 690 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4627 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39354 | 0.040 |
Why?
|
Pancreatitis | 1 | 2007 | 1087 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12077 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2007 | 1281 | 0.040 |
Why?
|
Psychotic Disorders | 1 | 2015 | 3276 | 0.040 |
Why?
|
Drug Carriers | 1 | 2024 | 710 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4428 | 0.040 |
Why?
|
Ferrosoferric Oxide | 1 | 2020 | 348 | 0.040 |
Why?
|
Carcinoma, Medullary | 2 | 2011 | 116 | 0.040 |
Why?
|
Surgical Procedures, Operative | 1 | 2010 | 1933 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2907 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2016 | 65379 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2008 | 2885 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1171 | 0.040 |
Why?
|
Cell Movement | 1 | 2011 | 5213 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2005 | 6669 | 0.040 |
Why?
|
Laparotomy | 2 | 2015 | 458 | 0.040 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 1997 | 324 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3772 | 0.040 |
Why?
|
Oligopeptides | 1 | 2024 | 1194 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 127 | 0.040 |
Why?
|
Liver Diseases | 1 | 2007 | 1305 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4260 | 0.040 |
Why?
|
Prospective Studies | 4 | 2021 | 54924 | 0.040 |
Why?
|
Colonic Neoplasms | 2 | 2009 | 2541 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5536 | 0.040 |
Why?
|
Bipolar Disorder | 1 | 2015 | 5130 | 0.040 |
Why?
|
Bone Diseases | 1 | 2001 | 416 | 0.040 |
Why?
|
Capillary Permeability | 2 | 2013 | 772 | 0.040 |
Why?
|
Sirolimus | 1 | 2004 | 1540 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3447 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36741 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 1997 | 69 | 0.030 |
Why?
|
Pyridines | 1 | 2009 | 2894 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2006 | 1901 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2005 | 2055 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Software | 1 | 2010 | 4480 | 0.030 |
Why?
|
Incidence | 3 | 2016 | 21538 | 0.030 |
Why?
|
Genotype | 1 | 2011 | 13045 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11930 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1997 | 256 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12795 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 331 | 0.030 |
Why?
|
Young Adult | 5 | 2018 | 60066 | 0.030 |
Why?
|
Cyclohexanes | 1 | 1996 | 152 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1657 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2234 | 0.030 |
Why?
|
Plasminogen | 1 | 1995 | 144 | 0.030 |
Why?
|
Mammography | 1 | 2006 | 2433 | 0.030 |
Why?
|
Chronic Disease | 2 | 2010 | 9384 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2022 | 826 | 0.030 |
Why?
|
Acute Disease | 1 | 2006 | 7243 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7454 | 0.030 |
Why?
|
Corneal Neovascularization | 1 | 1997 | 184 | 0.030 |
Why?
|
Melanoma | 1 | 2013 | 5706 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13490 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26379 | 0.030 |
Why?
|
Surgicenters | 1 | 2014 | 37 | 0.030 |
Why?
|
S Phase | 1 | 1996 | 424 | 0.030 |
Why?
|
Organizational Culture | 1 | 2018 | 513 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 1003 | 0.030 |
Why?
|
Injections | 1 | 2017 | 841 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2005 | 2956 | 0.030 |
Why?
|
Models, Biological | 1 | 2010 | 9497 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 796 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.030 |
Why?
|
Affective Disorders, Psychotic | 1 | 2015 | 187 | 0.030 |
Why?
|
Social Justice | 1 | 2018 | 486 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13422 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 860 | 0.030 |
Why?
|
Hypoparathyroidism | 1 | 2014 | 136 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2023 | 22380 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 751 | 0.030 |
Why?
|
Laser Therapy | 2 | 1990 | 1107 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1864 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2016 | 452 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17623 | 0.030 |
Why?
|
Hyperplasia | 1 | 1995 | 1151 | 0.030 |
Why?
|
Reoperation | 2 | 2015 | 4329 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2007 | 2442 | 0.020 |
Why?
|
Hemorrhage | 1 | 2004 | 3466 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4978 | 0.020 |
Why?
|
Chromatin | 1 | 2024 | 2981 | 0.020 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 40 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1105 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1995 | 1497 | 0.020 |
Why?
|
Vascular Surgical Procedures | 2 | 1990 | 1508 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 820 | 0.020 |
Why?
|
Child, Preschool | 3 | 2014 | 42669 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 16044 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3683 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2022 | 2237 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 338 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2010 | 150 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3833 | 0.020 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2010 | 101 | 0.020 |
Why?
|
Cell Nucleus Size | 1 | 2010 | 10 | 0.020 |
Why?
|
Cell Nucleus Shape | 1 | 2010 | 16 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1995 | 1744 | 0.020 |
Why?
|
HeLa Cells | 1 | 2016 | 3074 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2009 | 5151 | 0.020 |
Why?
|
Seroma | 1 | 2010 | 75 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1505 | 0.020 |
Why?
|
Up-Regulation | 2 | 2013 | 4149 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2048 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3773 | 0.020 |
Why?
|
Angiopoietin-2 | 1 | 2010 | 186 | 0.020 |
Why?
|
Anastomosis, Surgical | 2 | 1990 | 991 | 0.020 |
Why?
|
Estradiol | 1 | 1997 | 1951 | 0.020 |
Why?
|
Carbachol | 1 | 1989 | 223 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2010 | 156 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4352 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2050 | 0.020 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 58 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 249 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2009 | 147 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2015 | 1138 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 9016 | 0.020 |
Why?
|
Caspase 8 | 1 | 2009 | 198 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2003 | 749 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 371 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4585 | 0.020 |
Why?
|
Thrombospondins | 1 | 2009 | 196 | 0.020 |
Why?
|
Preoperative Period | 1 | 2010 | 565 | 0.020 |
Why?
|
Indocyanine Green | 1 | 1990 | 239 | 0.020 |
Why?
|
Child | 4 | 2014 | 80917 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2009 | 405 | 0.020 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 195 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 74944 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1997 | 2819 | 0.020 |
Why?
|
Genes, ras | 1 | 2010 | 663 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2009 | 342 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 626 | 0.020 |
Why?
|
Prevalence | 1 | 2004 | 15869 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4620 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1989 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6525 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2496 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6975 | 0.020 |
Why?
|
Chlorides | 1 | 1989 | 666 | 0.020 |
Why?
|
Fibrinogen | 1 | 1990 | 891 | 0.020 |
Why?
|
Trypanosoma brucei brucei | 1 | 1986 | 43 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1754 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2010 | 667 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1832 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1140 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1146 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 19025 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1966 | 0.010 |
Why?
|
Pregnancy | 1 | 2007 | 30255 | 0.010 |
Why?
|
Cholecystography | 1 | 2004 | 42 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2010 | 1271 | 0.010 |
Why?
|
Glycoproteins | 2 | 1997 | 2202 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9613 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 30009 | 0.010 |
Why?
|
Gangrene | 1 | 2004 | 92 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2264 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8080 | 0.010 |
Why?
|
Laparoscopy | 1 | 2015 | 2041 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 14164 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2357 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3590 | 0.010 |
Why?
|
Delirium | 1 | 2015 | 1696 | 0.010 |
Why?
|
Phosphates | 1 | 2006 | 765 | 0.010 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2003 | 147 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7452 | 0.010 |
Why?
|
Genes | 1 | 1986 | 1824 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14783 | 0.010 |
Why?
|
Cholecystectomy | 1 | 2004 | 408 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4672 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5884 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3081 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8375 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2003 | 7609 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3655 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10099 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2001 | 963 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2828 | 0.010 |
Why?
|
ras Proteins | 1 | 2003 | 1058 | 0.010 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 1997 | 75 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5330 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14488 | 0.010 |
Why?
|
Tumor Stem Cell Assay | 1 | 1997 | 116 | 0.010 |
Why?
|
Aorta, Abdominal | 2 | 1990 | 627 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 1997 | 97 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13290 | 0.010 |
Why?
|
Depression | 1 | 2016 | 8230 | 0.010 |
Why?
|
H-2 Antigens | 1 | 1997 | 359 | 0.010 |
Why?
|
Simian virus 40 | 1 | 1997 | 292 | 0.010 |
Why?
|
Angiostatins | 1 | 1995 | 64 | 0.010 |
Why?
|
Luciferases | 1 | 1997 | 713 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1997 | 866 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2000 | 1836 | 0.010 |
Why?
|
Androstadienes | 1 | 1997 | 348 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 1997 | 386 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2000 | 2125 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1997 | 11101 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 434 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 1997 | 662 | 0.010 |
Why?
|
Endothelium | 1 | 1997 | 768 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20225 | 0.010 |
Why?
|
Rabbits | 2 | 1990 | 4773 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1997 | 1524 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1995 | 594 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15453 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 13091 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12422 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24318 | 0.010 |
Why?
|
Genetic Variation | 1 | 1986 | 6610 | 0.010 |
Why?
|
Tissue Survival | 1 | 1990 | 120 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 1990 | 53 | 0.010 |
Why?
|
Ionomycin | 1 | 1989 | 110 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1989 | 166 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1989 | 657 | 0.000 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1990 | 945 | 0.000 |
Why?
|
Chelating Agents | 1 | 1989 | 385 | 0.000 |
Why?
|
Cornea | 1 | 1995 | 1316 | 0.000 |
Why?
|
Sodium Chloride | 1 | 1990 | 584 | 0.000 |
Why?
|
Fibrin | 1 | 1990 | 514 | 0.000 |
Why?
|
Variant Surface Glycoproteins, Trypanosoma | 1 | 1986 | 8 | 0.000 |
Why?
|
Electrophysiology | 1 | 1989 | 1266 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1990 | 769 | 0.000 |
Why?
|
Pressure | 1 | 1990 | 1172 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3728 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1986 | 548 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1989 | 1470 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1986 | 1305 | 0.000 |
Why?
|
Karyotyping | 1 | 1986 | 1177 | 0.000 |
Why?
|
Molecular Weight | 1 | 1986 | 2173 | 0.000 |
Why?
|
Chromosomes | 1 | 1986 | 578 | 0.000 |
Why?
|
Rats | 1 | 1997 | 23782 | 0.000 |
Why?
|
Homeostasis | 1 | 1989 | 3348 | 0.000 |
Why?
|
DNA | 1 | 1986 | 7213 | 0.000 |
Why?
|